Skip to the answer

Tezepelumab Injection Uses, Dosage, Side Effects and Interactions

Brand name
Tezspire

Tezspire was the first tezepelumab injection product the FDA approved, in 2021.

Tezepelumab Injection is a once-monthly add-on biologic medicine for severe asthma and for chronic rhinosinusitis with nasal polyps (nasal polyps with long-lasting sinus inflammation) in people 12 and older.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Tezepelumab InjectionType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Tezepelumab Injection in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Tezepelumab (Tezspire) is one of the newer biologic injections, prescribed by specialists and on the U.S. market since about 2021, added on to regular treatment for severe asthma and for chronic sinusitis with nasal polyps in people 12 and older. It works by blocking TSLP, an early signal that sets off airway inflammation, which lowers markers such as eosinophils (allergy-type white blood cells). Most people tolerate it well, and what they notice is usually a sore throat, cold-like symptoms, joint or back pain, or redness where the shot went in. Watch for an allergic reaction, which can appear hours or even days after a shot, and get emergency help for swelling or trouble breathing.

Key Takeaways From the HelloPharmacist Team

  • Expect a shot under the skin every 4 weeks, given at the clinic or at home, as your prescriber decides.
  • Keep carrying your rescue inhaler, because tezepelumab works over time to prevent flare-ups and does nothing for a sudden asthma attack.
  • Do not cut back or stop steroid medicines on your own, since any reduction should be gradual and supervised by your doctor.
  • Avoid live vaccines while you are on it, and check with your prescriber before getting any vaccine.

How we write and review this content: our editorial policy

Tezepelumab Injection by the Numbers

Earliest FDA record
2021
Rank by Medicaid prescriptions
#673 of 1,666 drugs
More prescriptions than 59% of the 1,666 drugs we measure
42,607 prescriptions, Q1–Q4 2025

Patient Information Guide for Tezepelumab Injection

What It’s Used For

Tezepelumab Injection (TEZSPIRE) is an add-on maintenance treatment for:

  • Severe asthma in adults and children 12 and older. It is not for acute bronchospasm or status asthmaticus.
  • Inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adults and children 12 and older.

How It Works

Tezepelumab is a human monoclonal antibody (a lab-made protein). It binds to TSLP, a protein from airway and nasal lining cells that sits high in the inflammation chain. Blocking TSLP lowers inflammation markers such as blood eosinophils, IgE, FeNO, IL-5 and IL-13.

The exact way it works in asthma and nasal polyps has not been definitively established.

Drug Class

Drug Class

  • Thymic Stromal Lymphopoietin Blocker
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Thymic Stromal Lymphopoietin Blocker

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Thymic Stromal Lymphopoietin Blockers

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Tezepelumab Injection in the FDA’s index.

From our Patient Information GuideTezepelumab is a human monoclonal antibody (a lab-made protein). It binds to TSLP, a protein from airway and nasal lining cells that sits high in the inflammation chain. Read How Tezepelumab Injection Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Tezepelumab Injection in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other systemic drugs for obstructive airway diseases

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

TEZSPIRE is injected under the skin once every 4 weeks.

  • The vial and pre-filled syringe are given by a healthcare provider.
  • The pre-filled pen can be used by patients or caregivers after training, if the provider agrees.
  • Injection sites are the thigh or abdomen (not within 2 inches of the navel). A provider or caregiver may also use the upper arm. Rotate sites.
  • Let it warm to room temperature (about 60 minutes). Do not shake it or put it back in the fridge.
  • If you miss a dose, give it as soon as possible, then go back to your usual schedule.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Severe asthma (add-on maintenance treatment)

For adults and children 12 years and older
Usual dose 210 mg once every 4 weeks
  • 210 mg administered subcutaneously once every 4 weeks

Chronic stuffy, swollen sinuses with nasal polyps (add-on maintenance treatment)

For adults and children 12 years and older
Usual dose 210 mg once every 4 weeks
  • 210 mg administered subcutaneously once every 4 weeks

Good to Know for Every Dose

If a dose is missed, administer as soon as possible, then resume the usual day of administration; if the next dose is already due, administer as planned

See the Full Dosing Instructions on DailyMed →

Side Effects

Common side effects seen in studies include:

Common side effects

  • Sore throat (pharyngitis)
  • Joint pain (arthralgia)
  • Back pain
  • Stuffy or runny nose and throat irritation (nasopharyngitis)
  • Upper respiratory infection
  • Nosebleeds (epistaxis)
  • Flu
  • Injection site reactions such as redness, swelling or pain

When to get medical help

  • Get emergency help for signs of a severe allergic reaction (anaphylaxis). These can happen within hours, or sometimes days later.
  • Call your doctor if you develop a rash or red, itchy eyes (allergic conjunctivitis) after an injection.
  • Call your doctor if your asthma stays uncontrolled or gets worse during treatment.
  • Call your doctor if you develop a parasitic worm infection that does not improve with treatment.
  • Do not use TEZSPIRE to treat a sudden asthma attack. Get urgent medical help for one.

Warnings and Precautions

  • Allergic reactions: rash, allergic conjunctivitis and anaphylaxis have occurred, sometimes days after the dose.
  • Not a rescue medicine: do not use it for sudden asthma symptoms. Seek medical advice if asthma worsens.
  • Steroids: do not stop them abruptly. Reduce gradually under a doctor's supervision.
  • Parasitic infections: treat existing worm infections first.
  • Vaccines: avoid live attenuated vaccines.
  • Heart events: a long-term asthma study found more serious cardiac events with TEZSPIRE than placebo, of varied types.

Interactions

No formal drug interaction studies have been done.

  • Live attenuated vaccines: use has not been evaluated and should be avoided.
  • Steroids: do not stop suddenly when starting TEZSPIRE.
  • Leukotriene receptor antagonists, theophylline or aminophylline, and oral or inhaled corticosteroids did not meaningfully change tezepelumab clearance.

Interactions Listed in the FDA-Approved Label

From the Tezepelumab Injection prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

No formal drug interaction studies have been performed with TEZSPIRE.

Read the label’s full interactions text

7 DRUG INTERACTIONS No formal drug interaction studies have been performed with TEZSPIRE.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if you are allergic to tezepelumab-ekko or any of its ingredients.
  • Tell your doctor about any parasitic worm infection.
  • Pregnancy: there are no human data. Uncontrolled asthma also carries risks in pregnancy.
  • Breastfeeding: effects on infants are unknown, so discuss it with your doctor.
  • Children: not established under 12.
  • Older adults: no overall differences in safety or effectiveness.
  • Kidney: not studied in severe kidney impairment. Mild to moderate impairment did not change clearance.
  • Liver: no formal studies, and changes in liver function are not expected to affect clearance.

Half-Life and How Your Body Processes It

After injection under the skin, blood levels peak in about 3 to 10 days. About 77% of the dose is absorbed. Steady levels are reached after about 12 weeks of every-4-week dosing. It is broken down by the body's ordinary protein-clearing enzymes rather than liver enzymes, and its half-life is about 26 days. Age, sex and race did not meaningfully affect it. Higher body weight lowered exposure but did not require dose changes.

Storage

Store refrigerated between 36°F to 46°F (2°C to 8°C). Refrigerator once TEZSPIRE has reached room temperature. Refrigerator, TEZSPIRE must be used within 30 days or discarded.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Tezepelumab Injection

From the licensed clinical database we use, rolled up per supplement, most serious first.

52 supplements and herbal products have documented interactions with Tezepelumab Injection in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 51Moderate
  • 1Minor

See the other 44

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Tezepelumab Injection: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Tezepelumab Injection — the kind of thing our pharmacy team would talk through with you at the counter.

What is tezepelumab injection used for?

It is an add-on treatment for severe asthma and for chronic rhinosinusitis with nasal polyps that is not well controlled. It is for people 12 and older and is used alongside your usual medicines. It is not a rescue medicine for sudden asthma attacks.

What happens if I miss a dose of tezepelumab injection?

Give the missed dose as soon as you can. Then go back to your usual schedule. If your next dose is already due, just take it as planned.

Can I stop my steroid medicines when I start tezepelumab injection?

No, not suddenly. Stopping steroids abruptly can cause withdrawal symptoms or bring back hidden conditions. If your steroid dose is reduced, it should be gradual and supervised by your doctor.

What side effects should I expect with tezepelumab injection?

The most common are sore throat, joint pain and back pain. In nasal polyp studies, colds, nosebleeds, flu and injection site reactions were also seen. Get emergency help if you have signs of a serious allergic reaction, like trouble breathing or swelling.

Can I get vaccines while taking tezepelumab injection?

You should avoid live attenuated vaccines, because their use with this medicine has not been studied. Check with your prescriber or pharmacist before any vaccine.

Can I give myself tezepelumab injection at home?

Only the pre-filled pen can be used by patients or caregivers, and only after training if your provider agrees. The vial and pre-filled syringe are given by a healthcare provider. Let it warm to room temperature first and do not shake it.

Is tezepelumab injection available over the counter?

No. Tezepelumab injection is a prescription medicine: every tezepelumab injection product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was tezepelumab injection first available?

The earliest FDA record we hold for tezepelumab injection is from 2021: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when tezepelumab injection was first used.

What is the brand name of tezepelumab injection?

Tezepelumab injection is the generic name. Its brand name is Tezspire.

What is the generic name of Tezspire?

The generic name of Tezspire is tezepelumab injection. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is tezepelumab injection?

Tezepelumab injection belongs to the drug class Thymic Stromal Lymphopoietin Blocker, its established pharmacologic class on the FDA label.

Where can I read the tezepelumab injection prescribing information (package insert)?

The full FDA-approved prescribing information for tezepelumab injection, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Amgen, Inc's, revised Oct 17, 2025, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Tezepelumab Injection

Skip the scrolling. Ask in your own words and get an answer from Tezepelumab Injection’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Tezepelumab Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Tezepelumab Injection on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Tezepelumab Injection Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Tezepelumab Injection on the U.S. Market: Products, Makers and Brands

How Tezepelumab Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

The FDA lists Tezepelumab Injection products; the earliest marketing or approval year on record is 2021.

1
Brand names ⓘ
2021
Earliest FDA record ⓘ

How Widely Tezepelumab Injection Is Used (Medicaid Data)

How many Tezepelumab Injection prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

42,607
Medicaid prescriptions filled (Q1–Q4 2025)
$179.9M paid by Medicaid, before rebates

How commonly is Tezepelumab Injection prescribed? Of the 1,666 medications we measure, Tezepelumab Injection ranks #673 by Medicaid prescriptions — more than 60% of them.

Where Tezepelumab Injection ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Tezepelumab Injection product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 1.91 mL / 110 mg/mL auto-injector is the most-dispensed Tezepelumab Injection product — about 61% of these Medicaid prescriptions.

1.91 ML tezepelumab-ekko 110 MG/ML Auto-Injector Most dispensed

25,908 Medicaid prescriptions (Q1–Q4 2025) 61% of Tezepelumab Injection prescriptions shown $120.4M paid by Medicaid, before rebates ≈ $4,647 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 2628920

1.91 ML tezepelumab-ekko 110 MG/ML Prefilled Syringe

16,699 Medicaid prescriptions (Q1–Q4 2025) 39% of Tezepelumab Injection prescriptions shown $59.5M paid by Medicaid, before rebates ≈ $3,565 per prescription, before rebates

1 of 3 listed NDCs had Medicaid claims. RxNorm 2587803

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 2 of the 5 listed Tezepelumab Injection NDCs had Medicaid claims.

Tezepelumab Injection Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Tezepelumab Injection — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Tezepelumab Injection are asthma, dyspnoea, arthralgia; about 45% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

6,931
Reports mentioning it
45%
Reported as serious
12
Distinct effects shown
Most reported effects
Asthma
1,067
Dyspnoea
649
Arthralgia
551
Cough
342
Pneumonia
294
Fatigue
273
Headache
259
Back Pain
242
Rash
239
Pain
233
Age groups
Adult · 1,216Elderly · 667Adolescent · 40Child · 5Neonate · 1

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Tezepelumab Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Tezepelumab Injection FDA Approval History

How Tezepelumab Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Tezepelumab Injection was first approved by the FDA in 2021 (Brand: TEZSPIRE · Astrazeneca Ab). It remains available in U.S. pharmacies today.

2021
Brand approved
Brand: TEZSPIRE · Astrazeneca Ab
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Tezepelumab Injection Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Tezepelumab recalls since July 2021.

✅No Tezepelumab recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 12, 2026.

Tezepelumab Injection in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
2
Forms in current FDA listings
0 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Tezepelumab Injection RxCUI 2587789
  1. Dose form (SCDF) Auto-Injector RxCUI 2628919
    No current FDA listing
    Its strength (SCD)
  2. Dose form (SCDF) Prefilled Syringe RxCUI 2587802
    No current FDA listing
    Its strength (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Tezepelumab Injection Brand Names

Tezepelumab Injection has one brand name on record: Tezspire. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Tezspire the first brand, 2021

Sources for This Tezepelumab Injection Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Oct 17, 2025, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Tezepelumab Injection.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 2 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
2
Linked representative label ⓘ
Amgen, Inc
Linked label effective
Oct 17, 2025
Composite sections available
21
Linked SPL Set ID
60f0aa03-ad25-4d48-80ce-7fcfa76f325f
Linked SPL Document ID
4eca89a7-2254-4ee1-9662-c7a84ef7c4b9
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Amgen, Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →